Delving into the Latest Updates on Shanghai New Asiatic Pharmaceuticals Co., Ltd. with Synapse

Overview

Tags

Other Diseases

Infectious Diseases

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3
Infectious Diseases	3
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	9

Top 5 Target	Count

PBPs(Bacterial penicillin-binding protein)	3
GABAA receptor(Gamma-aminobutyric acid A receptor)	2
β-adrenoceptors(Beta adrenergic receptors)	1
Opioid receptors	1

A synthesis method of methoxyamine was introduced.Process route, technol. conditions and separation method were discussed.The optimum process conditions was determined as follows: the SO₂ temperature is less than 0 °C, the absorption end point is pH = 4.0, the methylation temperature is 50 °C, the reaction time is 4 h, and the hydrolysis reflux is 4 h.This synthesis method can be directly used in industry production

Zhongguo Yiyao Gongye Zazhi

Preparation of crystalline acyclovir sodium for injection

Author: Chen, Chengqing ; Jiang, Guokun

Crystalline acyclovir sodium for injection was prepared by crystallization in ethanol.Its quality and stability were studied.The effects of solvent, temperature, and stir speed on crystallization were discussed.

Jingxi Shiyou Huagong Jinzhan

Fe/ZnO photocatalytic degradation of methylene blue

Author: Zhang, Yi

Fe/ZnO photocatalyst was prepared by impregnation method with Fe (NO₃)₃·9 H₂O and ZnO as raw materials.And the catalytic degradation performance of Fe/ZnO photocatalyst on methylene blue was investigated.The effects of catalyst dosage, initial concentration of methylene blue solution, reaction time, light source, and light power on the catalytic degradation of methylene blue were explored in details.Results showed that the degradation rate of methylene blue could reach 88% under the conditions of catalyst dosage of 0.2 g, 20 mL methylene blue solution of 10 mg/L, xenon lamp used as the light source with 1000 W for reacting 3 h.When using mercury lamp power as the light source with 400 W for reacting 40 min, the degradation rate of methylene blue was close to 100%.

100 Deals associated with Shanghai New Asiatic Pharmaceuticals Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai New Asiatic Pharmaceuticals Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Phase 3 Clinical

NDA/BLA

1

6

Approved

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Loperamide Hydrochloride ( Opioid receptors )	Diarrhea More	Approved
Pentobarbital Sodium ( GABAA receptor )	Sedation More	Approved
Amobarbital sodium ( GABAA receptor )	Sedation More	Approved
Aminethronii Hydrobromidum	Coma More	Approved
Carbenicillin Disodium ( PBPs )	Pseudomonas Infections More	Approved